- Company Overview
- Greetings
- Branch and Office Locator
- Research & Development
- Our Efforts for the Environment and Quality
Corporate History
| 1947 | Foundation of Daiichi Pure Chemical Co., Ltd. Start-up of domestic production of in vitro diagnostic reagents |
|---|---|
| 1955 | Establishment of the first commercial radioisotope laboratory |
| 1958 | Start-up of manufacturing and research on radiopharmaceuticals Start-up of manufacturing and sale of amino acids |
| 1963 | Release of the first domestic radiopharmaceuticals |
| 1965 | Completion of the ADME & Tox. Research Institute |
| 1968 | Start-up of laboratory contract business for safety research |
| 1978 | Completion of the Iwate Plant |
| 1990 | Completion of the Tsukuba Plant |
| 1992 | Completion of the Tsukuba Research Institute |
| 2001 | Establishment of a representative office in the United States ISO 14001 certification (Iwate Plant) |
| 2003 | ISO 9001 certification (Tsukuba Plant) |
| 2005 | ISO13485 certification (Tsukuba Plant) |
| 2006 | The company became a wholly owned subsidiary of Sekisui
Chemical Co., Ltd. after Daiichi Pharmaceutical Co., Ltd. transferred all
the company stocks. Establishment of a diagnostic reagent sales subsidiary in the city of Shanghai, China |
| 2008 | Establishment of SEKISUI MEDICAL Co., Ltd. (The company name was changed to SEKISUI MEDICAL Co., Ltd. after management integration with the Medical Products Division of Sekisui Chemical Co., Ltd.) Expansion of the ADME & Tox. Research Business into the overseas market (Sekisui Chemical Co., Ltd. acquired 100% of the shares of XenoTech, LLC. in the U.S. State of Kansas.) |
| 2009 | Expansion of the diagnostic reagents business will be strongly promoted in North America mainly （Sekisui Chemical Co., Ltd. acquired 100% of the shares of American Diagnostica Inc. in the U.S. State of Connecticut.） |
